Podcast #261: Icatibant

Podcast #261: Icatibant

Author: Aaron Lessen, M.D.

Educational Pearls

  • Icatibant was introduced to treat ACE-inhibitor induced angioendema.
  • This type of angioedema is refractory to epinephrine and antihistamines, and is likely mediated by elevated bradykinin.(which is inactivated by ATII and ACE).
  • Icatibant initially was shown to reduce facial swelling and airway obstruction in the setting of ACE-I angioedema, but later, better-powered studies showed that it had no benefit compared to standard treatment.

References: Sinert R et al. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema. J Allergy Clin Immunol Pract 2017. PMID: 28552382

Episoder(1149)

Populært innen Vitenskap

fastlegen
rekommandert
tingenes-tilstand
forskningno
sinnsyn
rss-rekommandert
smart-forklart
liberal-halvtime
villmarksliv
jss
fjellsportpodden
pod-britannia
vett-og-vitenskap-med-gaute-einevoll
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
psykopoden
dekodet-2
rss-nysgjerrige-norge
nevropodden
rss-overskuddsliv